Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, primary form of mineralocorticoid resistance characterized by mild to profound salt wasting either restricted to the kidney (renal pseudohypoaldosteronism type 1), or generalized affecting many organs (generalized pseudohypoaldosteronism type 1). Clinical presentation is in the neonatal period with failure to thrive, vomiting and dehydration with biochemical findings of hyperkalaemia, metabolic acidosis and, elevated plasma aldosterone and renin concentration.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
27 publications have been identified in PubMed for pseudohypoaldosteronism type 1. Research spans Case Report / Case Series (74%), Review / Meta-Analysis (19%), and Basic Science / Preclinical (4%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 20 | 74% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 9:39 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries |
5 |
19% |
Laboratory research | 1 | 4% |
Disease patterns and progression | 1 | 4% |
Bolaç Özyılmaz LG (2026). [PMID: 41275343](https://pubmed.ncbi.nlm.nih.gov/41275343/). *J Pediatr Endocrinol Metab*. [Case Report / Case Series]
Tajima T (2026). [PMID: 41905953](https://pubmed.ncbi.nlm.nih.gov/41905953/). *Endocr J*. [Review / Meta-Analysis]
Martinerie L (2026). [PMID: 41543024](https://pubmed.ncbi.nlm.nih.gov/41543024/). *J Endocrinol*. [Review / Meta-Analysis]
Abd El-Aziz TM (2026). [PMID: 41498836](https://pubmed.ncbi.nlm.nih.gov/41498836/). *Purinergic Signal*. [Review / Meta-Analysis]
Wang Z (2026). [PMID: 41457049](https://pubmed.ncbi.nlm.nih.gov/41457049/). *Mol Genet Genomic Med*. [Case Report / Case Series]
Bahadoran E (2026). [PMID: 41522852](https://pubmed.ncbi.nlm.nih.gov/41522852/). *Clin Case Rep*. [Case Report / Case Series]
Wu Z (2026). [PMID: 41982973](https://pubmed.ncbi.nlm.nih.gov/41982973/). *Transl Pediatr*. [Case Report / Case Series]
Kuchay MS (2026). [PMID: 42057493](https://pubmed.ncbi.nlm.nih.gov/42057493/). *Nephrology (Carlton)*. [Case Report / Case Series]
Alquraishi A (2026). [PMID: 42077744](https://pubmed.ncbi.nlm.nih.gov/42077744/). *Cureus*. [Case Report / Case Series]
Ma H (2026). [PMID: 42146936](https://pubmed.ncbi.nlm.nih.gov/42146936/). *Front Pediatr*. [Case Report / Case Series]